Log in

OTCMKTS:PHMMF - Pharma Mar Stock Price, Forecast & News

$4.44
-0.01 (-0.22 %)
(As of 03/29/2020 04:59 AM ET)
Today's Range
$4.44
Now: $4.44
$4.47
50-Day Range
$2.82
MA: $4.48
$5.44
52-Week Range
$1.68
Now: $4.44
$5.49
Volume4,900 shs
Average Volume5,654 shs
Market Capitalization$982.57 million
P/E RatioN/A
Dividend YieldN/A
Beta0.37
Pharma Mar, S.A., a biopharmaceutical company, engages in the discovery and development of marine-derived anticancer drugs in Spain and internationally. The company operates through two segments, Biopharmaceuticals and Consumer Chemicals. It develops and commercializes Yondelis, an antitumor agent for the treatment of advanced soft tissue sarcomas and for relapsed ovarian cancer. The company also develops clinical-stage programs, including Aplidin, Lurbinectedin, PM184, and PM14. In addition, it develops and provides diagnostics kit for genetic diagnostics and DNA analysis; and produces and markets insecticides and air fresheners for household use, household products, wood treatment and decoration products, paints, and similar products. Pharma Mar, S.A. was founded in 1986 and is based in Madrid, Spain.
Read More
Pharma Mar logo

Industry, Sector and Symbol

Industry Private households
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:PHMMF
Previous SymbolNASDAQ:PHMMF
CUSIPN/A
CIKN/A
Phone34-91-846-6000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$192.01 million
Book Value$0.09 per share

Profitability

Miscellaneous

Employees599
Market Cap$982.57 million
Next Earnings Date4/2/2020 (Estimated)
OptionableNot Optionable

Receive PHMMF News and Ratings via Email

Sign-up to receive the latest news and ratings for PHMMF and its competitors with MarketBeat's FREE daily newsletter.


Pharma Mar (OTCMKTS:PHMMF) Frequently Asked Questions

How has Pharma Mar's stock been impacted by COVID-19 (Coronavirus)?

Pharma Mar's stock was trading at $3.50 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, PHMMF shares have increased by 26.9% and is now trading at $4.44. View which stocks have been mosted impacted by Coronavirus.

When is Pharma Mar's next earnings date?

Pharma Mar is scheduled to release its next quarterly earnings announcement on Thursday, April 2nd 2020. View our earnings forecast for Pharma Mar.

Has Pharma Mar been receiving favorable news coverage?

Media stories about PHMMF stock have trended somewhat positive recently, InfoTrie Sentiment reports. InfoTrie identifies positive and negative media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Pharma Mar earned a news impact score of 1.2 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the next few days. View the latest news aboutPharma Mar.

Who are some of Pharma Mar's key competitors?

What other stocks do shareholders of Pharma Mar own?

Who are Pharma Mar's key executives?

Pharma Mar's management team includes the following people:
  • Dr. José María Fernández Sousa-Faro Ph.D., Founder, Exec. Chairman, CEO & Pres
  • Mr. Pedro Fernández Puentes, Exec. Vice-Chairman
  • Mr. Juan Carlos-Torres Carretero, Founder (Age 70)
  • Ms. María Luisa de Francia Caballero, Chief Financial Officer
  • Mr. Pascal Besman, Chief Operating Officer

What is Pharma Mar's stock symbol?

Pharma Mar trades on the OTCMKTS under the ticker symbol "PHMMF."

How do I buy shares of Pharma Mar?

Shares of PHMMF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Pharma Mar's stock price today?

One share of PHMMF stock can currently be purchased for approximately $4.44.

How big of a company is Pharma Mar?

Pharma Mar has a market capitalization of $982.57 million and generates $192.01 million in revenue each year. The company earns $-6,540,000.00 in net income (profit) each year or ($0.09) on an earnings per share basis. Pharma Mar employs 599 workers across the globe. View additional information about Pharma Mar.

What is Pharma Mar's official website?

The official website for Pharma Mar is http://www.pharmamar.com/.

How can I contact Pharma Mar?

Pharma Mar's mailing address is Avda. De los Reyes 1 Pol. Ind. La Mina, Madrid U3, 28770. The company can be reached via phone at 34-91-846-6000 or via email at [email protected]


MarketBeat Community Rating for Pharma Mar (OTCMKTS PHMMF)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  203 (Vote Outperform)
Underperform Votes:  221 (Vote Underperform)
Total Votes:  424
MarketBeat's community ratings are surveys of what our community members think about Pharma Mar and other stocks. Vote "Outperform" if you believe PHMMF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PHMMF will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/29/2020 by MarketBeat.com Staff

Featured Article: Why do commodities matter?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel